Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations-Reference-Cited by-同舟云学术

Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations

Published:2021-03-16 Issue:3 Volume:194 Page:496-507
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Rosiñol Laura¹^ORCID,Beksac Meral²^ORCID,Zamagni Elena³,Van de Donk Niels W. C. J.⁴,Anderson Kenneth C.⁵,Badros Ashraf⁶,Caers Jo⁷,Cavo Michele³,Dimopoulos Meletios‐Athanasios⁸^ORCID,Dispenzieri Angela⁹,Einsele Hermann¹⁰^ORCID,Engelhardt Monika¹¹^ORCID,Fernández de Larrea Carlos¹,Gahrton Gösta¹²,Gay Francesca¹³,Hájek Roman¹⁴^ORCID,Hungria Vania¹⁵,Jurczyszyn Artur¹⁶^ORCID,Kröger Nicolaus¹⁷,Kyle Robert A.⁹,Leal da Costa Fernando¹⁸,Leleu Xavier¹⁹^ORCID,Lentzsch Suzanne²⁰,Mateos Maria V.²¹^ORCID,Merlini Giampaolo²²,Mohty Mohamad²³^ORCID,Moreau Philippe²⁴^ORCID,Rasche Leo¹⁰,Reece Donna²⁵,Sezer Orhan²⁶^ORCID,Sonneveld Pieter²⁷,Usmani Saad Z.²⁸,Vanderkerken Karin²⁹,Vesole David H.³⁰,Waage Anders³¹,Zweegman Sonja⁴,Richardson Paul G.⁵^ORCID,Bladé Joan¹

Affiliation:

1. Department of Hematology Hospital Clínic IDIBAPS University of Barcelona Barcelona Spain

2. Department of Hematology Ankara University Ankara Turkey

3. Istituto di Ematologia “Seràgnoli” Dipartamento di Medicina Specialistica Diagnostica e Sperimentale Università degli Studi Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy

4. Department of Hematology Amsterdam UMC VU University Amsterdam the Netherlands

5. Dana Farber Cancer Institute Harvard Medical School Boston MAUSA

6. University of Maryland at Baltimore Baltimore MD USA

7. Department of Clinical Hematology Centre Hospitalier Universitaire de Liège Liège Belgium

8. Hematology and Medical Oncology Department of Clinical Therapeutics National and Kapodistrian University of Athens Alexandra Hospital Athens Greece

9. Division of Hematology Mayo Clínic Rochester MN USA

10. Department of Internal Medicine II University Hospital Würzburg WürzburgGermany

11. Interdisciplinary Tumor Center University of Freiburg Freiburg Germany

12. Department of Medicine Karolinska Institutet, Huddinge Stockholm Sweden

13. Myeloma Unit Città della Salute e della Scienza University of Torino Torino Italy

14. Department of Haematooncology University of Ostrava Ostrava Czech Republic

15. Clinica São Germano São Paulo Brazil

16. Medical College Department of Hematology Jagiellanian University Krakow Poland

17. University Medical Center Hamburg‐Eppendorf Hamburg Germany

18. Instituto Português de Oncologia Lisboa Portugal

19. Poitiers University Hospital Poitiers France

20. Multiple Myeloma and Amyloidosis Service Columbia University New York NY USA

21. IBSAL Cancer Research Center University Hospital of Salamanca Salamanca Spain

22. Amyloidosis Research and Treatment Center Department of molecular Medicine University of Pavia Fondazione IRCCS Policlinico San Matteo Pavia Italy

23. Department of Clinical Hematology and Cellular Therapy Hospital Saint‐Antoine Sorbonne University ParísFrance

24. Hematology Department University Hospital Hotel‐Dieu Nantes France

25. Princess Margaret Cancer Center University of Toronto Toronto Canada

26. Berlín Germany

27. Erasmus MC Cancer Institute Erasmus University of Rotterdam Rotterdam the Netherlands

28. Department of Hematologic Oncology and Blood Disorders Levine Cancer institute/Atrium Health Charlotte NC USA

29. Department Hematology and Immunology Vriji Universiteit Brussel Brussels Belgium

30. John Theurer Cancer Hackensack Meridian School of Medicine Hackensat NJ USA

31. Department of Clinical Molecular Medicine St. Olavs Hospital NTNU Trondheim Trondheim Norway

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17338

Reference115 articles.

1. The Role of the Bone Marrow Microenvironment in the Pathophysiology of Myeloma and Its Significance in the Development of More Effective Therapies

2. Extravasation and homing mechanisms in multiple myeloma

3. Myeloma as a model for the process of metastasis: implications for therapy

4. Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach

5. The impact of extramedullary disease at presentation on the outcome of myeloma

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Negative effect of paraskeletal plasmacytoma on survival of patients with transplant-ineligible newly diagnosed multiple myeloma;Annals of Hematology;2024-01-16

2. Multiple myeloma extramedullary relapse at the sellar and suprasellar region after autologous stem cell transplantation;Surgical Neurology International;2024-01-12

3. Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R‐ISS II patients;HemaSphere;2024-01

4. Cytogenetic findings in testicular relapse of multiple myeloma: case report and literature review;Hematology, Transfusion and Cell Therapy;2024-01

5. The Singular Epidemiology of Plasmacytoma and Multiple Myeloma in French Guiana;Cancers;2023-12-29